Combating the Increasing
Threat of Multi-drug Resistant
Bacterial Infections in the
Hospital and Community Setting

As a multi-asset, clinical-stage biopharmaceutical
company, Spero Therapeutics is focused on identifying,
developing and commercializing novel treatments for
multi-drug resistant (MDR) bacterial infections.

Leading Product Candidates

Spero Therapeutics is developing a portfolio of novel product candidates with the potential for meaningful patient impact and significant commercial applications. Our candidates are designed to treat MDR bacterial infections in both the hospital and community settings.  

  • Investors

    Learn about the investment opportunity, see our upcoming events and download our latest corporate presentation.

    Investment opportunities >
  • Careers

    Join a passionate team that pushes the limits in finding innovative therapies to help patients. Named one of Boston’s Best Places to Work.

    Career opportunities >
  • Partners

    Our strategic partnerships foster mutually beneficial alliances that advance medicine to improve patient lives.

    Partnership opportunities >